English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

As diet represents a modifiable lifestyle factor that could potentially be used for cancer prevention and improvement of health outcomes, the role of healthy diet has long been an area of great interest in cancer research. After reviewing the article by Deshmukh et al. (1), we would like to bring to the readers’ attention several critical methodological concerns that undermine the validity of the findings. First, the authors did not adjust for stage of disease or treatment. It is well known that survival is strongly influenced by these factors. For example, breast cancer 5-year disease-free survival varies from 99% for stages IA/IB to 26% for stage IV (2). Similar patterns are observed for other cancers (5-year survival: 90% for stage I and 14% for stage IV colon cancer and >99% for local and 29% for distant prostate cancer, etc.) (2). Diet may also vary by disease stage or treatment (3). Thus, failing to adjust for stage and/or treatment may have led to biased results. Second, the study relied on a single 24-hour dietary recall that characterizes recent, short-term intake (4). As day-to-day withinperson variation in nutrient and food intake is substantial, a single dietary record does not provide robust information on typical diet and has been shown to introduce considerable misclassification (4). Long-term (habitual) diet is more relevant when investigating chronic diseases and long-term health outcomes (4). For this reason, studies evaluating effects of diet on health outcomes should include multiple dietary recalls or employ food frequency questionnaires that collect information on usual food consumption, typically over the previous year (4). Basing dietary status on a single 24-hour recall in the study by Deshmukh et al. (1) would have introduced substantial error in the characterization of usual diet and potential bias in the results. Further, the study relied on comorbidity information from the survey and did not take into consideration the time-varying nature of these important factors and resulting dietary changes. Additionally, diet reported by individuals recently diagnosed with cancer and still undergoing cancer treatment may not have been representative of diet over subsequent follow-up (3,5). Finally, the study was unable to separate melanoma from the far more common nonmelanoma skin cancers because of the survey questions’ format. Due to very specific nature of nonmelanoma skin cancers with respect to risk factors (mainly proxies for chronic sun exposure), their highly curable nature, and low death rates (6), individuals with nonmelanoma skin cancers are typically considered cancer-free individuals in epidemiologic studies of factors that contribute to other cancers’ risk and/or survival. That the study results were influenced by these important limitations is suggested by the contradictory finding that greater saturated fat intake is associated with better survival, which is inconsistent with extensive prior evidence demonstrating a negative influence of saturated fat on health outcomes, including cancer-specific mortality (7). Future studies on this important question should employ diet assessment methods that capture usual diet and account for key determinants of survival, such as disease stage and treatment, in order to obtain useful, unbiased association estimates.

RE: The Association Between Dietary Quality and Overall and Cancer-Specific Mortality Among Cancer Survivors, NHANES III